Top 10 research priorities in inflammatory bowel disease in Australia: findings using the James Lind Alliance approach
Crohn's disease and ulcerative colitis affect 180 000 people in Australia, have no cure, have variable responses to treatment and cause a large burden of disease. Using methods developed by the James Lind Alliance, the top 10 research priorities were identified by consumers and clinicians to facilitate the planning and funding of future research.
Authors
- Emma P. Halmos (ORCID: https://orcid.org/0000-0002-6063-5118)
- Paul Pavli (ORCID: https://orcid.org/0000-0003-1891-8410)
- Antonina Mikocka‐Walus (ORCID: https://orcid.org/0000-0003-4864-3956)
- Hailey Fisher
- Rimma Goldberg (ORCID: https://orcid.org/0000-0002-4984-8585)
- Susan J. Connor (ORCID: https://orcid.org/0000-0001-5606-0270)
- Leanne Raven (ORCID: https://orcid.org/0000-0003-3531-6075)
- Wayne Massuger (ORCID: https://orcid.org/0000-0002-1887-4107)
- Edward Giles (ORCID: https://orcid.org/0000-0003-3295-1575)
- Katherine Cowan
Institutions
- Australian National University (AU)
- New South Wales Department of Health (AU)
- Deakin University (AU)
- Liverpool Hospital (AU)
- Hudson Institute of Medical Research (AU)
- UNSW Sydney (AU)
- Monash Children’s Hospital (AU)
- Crohn's & Colitis Australia (AU)
- Monash Health (AU)
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1111/imj.70201
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00